or Try an Advanced Search...

    Technical Analysis for PYPD - PolyPid Ltd.

    Grade Last Price % Change Price Change
    F 3.30 3.13% 0.10
    PYPD closed up 3.13 percent on Friday, November 1, 2024, on 1.41 times normal volume.
    Earnings due: Nov 6
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PYPD trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Fell Below 20 DMA Bearish 3.13%
    Fell Below 50 DMA Bearish 3.13%
    MACD Bearish Signal Line Cross Bearish 3.13%
    Below Lower BB Weakness 3.13%
    Gapped Down Weakness 3.13%
    Lower Bollinger Band Touch Weakness 3.13%
    NR7 Range Contraction -6.78%
    Older End-of-Day Signals for PYPD ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 23 hours ago
    Gap Up Partially Closed 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    Rose Above 10 DMA 1 day ago
    20 DMA Resistance 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PYPD Chart by TradingView
    Basic chart:

    Profile

    PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID–500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Surgery Bone Phosphates Infection Antibiotics Lipid Polyp Incision Bone Grafting Surgical Site

    Is PYPD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 21 PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
    Oct 1 PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
    Sep 3 PolyPid to Participate in Three Upcoming Fall Investor Conferences
    Aug 30 PolyPid files to sell 3.91M ordinary shares for holders
    Aug 14 PolyPid Ltd (PYPD) Q2 2024 Earnings Call Transcript
    Aug 14 PolyPid GAAP EPS of -$1.25
    Aug 14 PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results
    Aug 2 PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds
    Jul 31 PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024
    Jul 29 Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
    See more PYPD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.2
    52 Week Low 2.95
    Average Volume 5,561
    200-Day Moving Average 4.44
    50-Day Moving Average 3.47
    20-Day Moving Average 3.43
    10-Day Moving Average 3.38
    Average True Range 0.24
    RSI (14) 45.36
    ADX 14.91
    +DI 18.22
    -DI 26.95
    Chandelier Exit (Long, 3 ATRs) 3.04
    Chandelier Exit (Short, 3 ATRs) 3.85
    Upper Bollinger Bands 3.63
    Lower Bollinger Band 3.23
    Percent B (%b) 0.17
    BandWidth 11.72
    MACD Line -0.04
    MACD Signal Line -0.03
    MACD Histogram -0.011
    Fundamentals Value
    Market Cap 15.83 Million
    Num Shares 4.8 Million
    EPS -23.64
    Price-to-Earnings (P/E) Ratio -0.14
    Price-to-Sales 0.00
    Price-to-Book 9.38
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.52
    Resistance 3 (R3) 3.54 3.49 3.48
    Resistance 2 (R2) 3.49 3.44 3.48 3.47
    Resistance 1 (R1) 3.40 3.40 3.37 3.37 3.46
    Pivot Point 3.35 3.35 3.34 3.34 3.35
    Support 1 (S1) 3.25 3.29 3.23 3.23 3.14
    Support 2 (S2) 3.20 3.26 3.19 3.13
    Support 3 (S3) 3.11 3.20 3.12
    Support 4 (S4) 3.08